COHORT To Go Ex-Dividend On August 22nd, 2024 With 0.13104 USD Dividend Per Share

Moomoo NewsJul 17 19:40 ET

Immune-Onc Therapeutics to Present Additional Positive Interim Data From IO-202 Phase 1b Expansion Cohort in Patients With Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual Congress

BusinesswireJun 14 03:00 ET

Express News | IN8bio, Inc. - Enrollment and Treatment of Patients Into Expansion Cohort Is Ongoing, With Updated Data Expected in Late 2024 and 2025

ReutersJun 13 16:03 ET

Express News | Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of Cendifox Trial

ReutersJun 13 08:30 ET

Express News | Pasithea Therapeutics Announces An Independent Safety Review Committee Completes Safety Review Of Data From First Dose Cohort In Phase 1 Trial Of PAS-004

BenzingaJun 13 07:07 ET

Express News | Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 Following Positive Safety Review Committee (Src) Recommendation for Pas-004 in Ongoing Phase 1 Clinical Trial

ReutersJun 13 06:59 ET